Hong-Ling Qiu
Overview
Explore the profile of Hong-Ling Qiu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li H, Zhang F, Gong S, Zhao Q, Luo C, Qiu H, et al.
Acad Radiol
. 2024 Dec;
32(3):1725-1733.
PMID: 39701846
Rationale And Objectives: Comprehensive data on the use of ventilation-perfusion single-photo emission computed tomography/computed tomography (V/Q SPECT/CT), an established diagnostic tool for chronic thromboembolic pulmonary hypertension, in identifying pulmonary hypertension...
2.
Xu J, Wang J, Zhao Q, Gong S, Wu W, Jiang R, et al.
J Hypertens
. 2024 Jun;
42(10):1703-1710.
PMID: 38860405
Objective: Pulmonary hypertension is a severe complication of bronchiectasis, characterized by elevated pulmonary vascular resistance (PVR) and subsequent right heart failure. The association between PVR and mortality in bronchiectasis-associated pulmonary...
3.
Xu W, Wang S, Zhao Q, Xu J, Hu X, Gong S, et al.
Front Immunol
. 2024 Jun;
15:1402250.
PMID: 38855107
Background: This study aimed to employ plasma proteomics to investigate the molecular changes, pathway alterations, and potential novel biochemical markers associated with balloon pulmonary angioplasty (BPA) in patients with chronic...
4.
Li H, Yuan P, Jiang R, Zhao Q, Sun Y, Zhang J, et al.
Intern Med J
. 2024 Apr;
54(8):1292-1301.
PMID: 38563467
Background And Aims: Sleep-disordered breathing (SDB) and nocturnal hypoxemia were known to be present in patients with chronic thromboembolic pulmonary hypertension (CTEPH), but the difference between SDB and nocturnal hypoxemia...
5.
Wang S, Yan Y, Zhang J, Yuan P, Luo C, Qiu H, et al.
Animal Model Exp Med
. 2023 Sep;
7(1):56-70.
PMID: 37740617
Background: The maintenance dosage of selexipag is categorized as low, medium or high. In order to assess the efficacy and safety of different dosages of selexipag for the risk stratification...
6.
Zhao H, Wang L, Yan Y, Zhao Q, He J, Jiang R, et al.
Front Immunol
. 2023 Sep;
14:1197752.
PMID: 37731513
Pulmonary fibrosis (PF) and pulmonary hypertension (PH) have common pathophysiological features, such as the significant remodeling of pulmonary parenchyma and vascular wall. There is no effective specific drug in clinical...
7.
Zhang R, Zhang J, Zhang Y, Gong S, Zhao Q, Wang X, et al.
Hypertension
. 2023 Jun;
80(8):1784-1794.
PMID: 37313754
Background: Idiopathic pulmonary hypertension (IPAH) is a rare and devastating disease often accompanied by persistent inflammation and immune responses. We aim to provide a reference atlas of neutrophils to facilitate...
8.
Liu Y, Qu Y, Wang S, Luo C, Qiu H, Li H, et al.
Front Pharmacol
. 2023 Mar;
14:1155631.
PMID: 36891269
[This corrects the article DOI: 10.3389/fphar.2023.1052546.].
9.
Liu Y, Qu Y, Wang S, Luo C, Qiu H, Li H, et al.
Front Pharmacol
. 2023 Feb;
14:1052546.
PMID: 36778016
Pulmonary arterial hypertension (PAH) is a rare and progressive disease. Some patients treated with phosphodiesterase type 5 inhibitors (PDE-5is) fail to reach treatment goals. As a novel soluble guanylate cyclase...
10.
Wang S, Guo Z, Sun X, Yuan P, Zhao Q, Wu W, et al.
Front Cardiovasc Med
. 2022 Dec;
9:976730.
PMID: 36578835
Objective: Whether exercise-induced venous-to-systemic shunt (EIS) during cardiopulmonary exercise testing (CPET) has different manifestations or characteristics in idiopathic pulmonary arterial hypertension (IPAH) and chronic thromboembolic pulmonary hypertension (CTEPH) patients remains...